Navitas Limited reports $40.4 million profit: Could now be the best time to buy?

Navitas Limited (ASX:NVT) has reaffirmed full year guidance.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Leading university pathways educator Navitas Limited (ASX: NVT) has fallen around 4% today after reporting a solid set of interim results. The group achieved a 14% increase in revenue to $480.5 million and a 12% increase in net profit after tax to $40.4 million, which equated to an 11% increase in earnings per share (excluding goodwill impairment) of 10.7 cents per share (cps). Shareholders will also receive a fully franked interim dividend of 9.4 cps which is in line with the prior corresponding period.

So What: The solid, double-digit results are an important milestone for Navitas after the high-flying business shocked the market in July last year when it announced that a long-term agreement with Macquarie University to provide pathway programs would be ending in 2016. The announcement sent the share price tumbling 30% to around $5 – a level it remains trading near today.

Now What: Today's results go some way to re-affirming investors' confidence in the company, however, even at $5 a share the stock is still arguably priced for perfection with high growth required to support the lofty price-to-earnings (PE) multiple. Based on the low end of management's full year guidance for earnings before interest, tax, depreciation and amortisation (EBITDA) of $162 million, the stock is trading on a PE of 21x.

Navitas remains a high-quality business and would be a welcome addition to many long-term portfolios if it was available at an appealing price. Given the high multiple the company trades on relative to the low-to-mid-double digit earnings growth profile, conservative investors may be best off leaving this one on their watch list for the time being.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned.  

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »